Austria will phase out AstraZeneca from its Covid-19 immunisation programme because of delivery problems and wariness among the population following reports of the vaccine's rare side effects.
Last week Chancellor Sebastian Kurz promised every adult in Austria who wants to be vaccinated against the coronavirus will be given the opportunity in the next 100 days. Will Austria meet this ambitious target?
The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.
The head of Austria’s vaccination committee has pledged to keep using AstraZeneca vaccines for under 60s, despite Germany’s decision to stop using the vaccine for this group
The European Medicines Agency (EMA) concluded on Thursday that the AstraZeneca vaccine was a "safe and effective" tool in the battle against Covid-19 but its investigation could not rule out whether the jab had caused rare cases of blood clotting.
The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears. It came as Brussels sealed a deal for 10 million more Pfizer doses.
Austria will continue using the AstraZeneca vaccine, despite several neighbouring countries including Germany, Italy, France, Spain and Slovenia this week saying they would suspend vaccinations from the manufacturer.
Austria has hit the one million mark of vaccines administered, with around 10 percent of the population getting at least one shot. What should we expect to see over the coming weeks?
Austrian Chancellor Sebastian Kurz promised on Friday he will publicly receive the AstraZeneca jab amid growing scepticism about the vaccine in several European countries.
Austria will stop using doses from one batch of the AstraZeneca vaccine while the death of a nurse who received it is investigated, health officials have said.
Despite concerns about its effectiveness, Austria is set to buck the trend of almost all of its neighbours in recommending the AstraZeneca vaccine for people aged over 65.
